This company listing is no longer active
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております!
Global Blood Therapeutics マネジメント
マネジメント 基準チェック /34
主要情報
Ted Love
最高経営責任者
US$8.2m
報酬総額
CEO給与 比率 | 8.7% |
CEO在任期間 | 8.3yrs |
CEOの所有権 | 1.4% |
経営陣の平均在職期間 | 6.5yrs |
取締役会の平均在任期間 | 5.8yrs |
経営陣の近況
Recent updates
CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$322m |
Mar 31 2022 | n/a | n/a | -US$310m |
Dec 31 2021 | US$8m | US$716k | -US$303m |
Sep 30 2021 | n/a | n/a | -US$277m |
Jun 30 2021 | n/a | n/a | -US$266m |
Mar 31 2021 | n/a | n/a | -US$249m |
Dec 31 2020 | US$18m | US$661k | -US$248m |
Sep 30 2020 | n/a | n/a | -US$282m |
Jun 30 2020 | n/a | n/a | -US$286m |
Mar 31 2020 | n/a | n/a | -US$291m |
Dec 31 2019 | US$10m | US$597k | -US$267m |
Sep 30 2019 | n/a | n/a | -US$220m |
Jun 30 2019 | n/a | n/a | -US$199m |
Mar 31 2019 | n/a | n/a | -US$182m |
Dec 31 2018 | US$10m | US$569k | -US$174m |
Sep 30 2018 | n/a | n/a | -US$166m |
Jun 30 2018 | n/a | n/a | -US$152m |
Mar 31 2018 | n/a | n/a | -US$135m |
Dec 31 2017 | US$8m | US$520k | -US$117m |
Sep 30 2017 | n/a | n/a | -US$103m |
Jun 30 2017 | n/a | n/a | -US$95m |
Mar 31 2017 | n/a | n/a | -US$89m |
Dec 31 2016 | US$1m | US$479k | -US$82m |
Sep 30 2016 | n/a | n/a | -US$71m |
Jun 30 2016 | n/a | n/a | -US$65m |
Mar 31 2016 | n/a | n/a | -US$58m |
Dec 31 2015 | US$2m | US$438k | -US$51m |
報酬と市場: Ted's total compensation ($USD8.19M) is above average for companies of similar size in the UK market ($USD2.71M).
報酬と収益: Ted's compensation has been consistent with company performance over the past year.
CEO(最高経営責任者
Ted Love (63 yo)
8.3yrs
在職期間
US$8,193,309
報酬
Dr. Ted W. Love, M.D., serves as Independent Director at Royalty Pharma plc since July 30, 2020. He serves as Director of Seagen Inc. (formerly known as Seattle Genetics, Inc.). since August 2020. He serve...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 8.3yrs | US$8.19m | 1.37% $ 63.2m | |
CFO & Principal Accounting Officer | 6.5yrs | US$2.76m | 0.040% $ 1.8m | |
Chief Business & Strategy Officer | 7.5yrs | US$2.73m | 0.37% $ 17.2m | |
Chief Commercial Officer | 4.6yrs | US$2.75m | 0.084% $ 3.9m | |
Executive VP and Head of Research & Development | 1.4yrs | US$2.98m | 0.0089% $ 409.5k | |
Founder & Advisor | 11.8yrs | データなし | データなし | |
Founder & Advisor | 11.8yrs | データなし | データなし | |
Founder & Advisor | 11.8yrs | データなし | データなし | |
Executive Vice President of Operations | 2.5yrs | データなし | 0.062% $ 2.9m | |
Senior Director of Corporate Communications & Investor Relations | no data | データなし | データなし | |
Chief Legal Officer & Secretary | 6yrs | US$5.93m | 0.064% $ 3.0m | |
Senior VP & Head of Corporate Communications | 3.8yrs | データなし | データなし |
6.5yrs
平均在職期間
60yo
平均年齢
経験豊富な経営陣: 0IVZ's management team is seasoned and experienced (6.5 years average tenure).
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 9.1yrs | US$8.19m | 1.37% $ 63.2m | |
Lead Independent Director | 7.5yrs | US$348.28k | 0.056% $ 2.6m | |
Independent Director | 4.8yrs | US$320.78k | 0.017% $ 783.3k | |
Independent Director | 2.4yrs | US$313.28k | 0.013% $ 618.8k | |
Independent Director | 6.7yrs | US$318.28k | 0.039% $ 1.8m | |
Independent Director | 7.1yrs | US$310.78k | 0.013% $ 623.9k | |
Independent Director | 6.8yrs | US$333.28k | 0.0098% $ 454.8k | |
Independent Director | 3.8yrs | US$316.36k | 0.0080% $ 368.3k | |
Advisor & Director Emeritus | less than a year | US$308.28k | 0.058% $ 2.7m | |
Independent Director | 1.6yrs | US$735.61k | 0.0049% $ 226.5k |
5.8yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: 0IVZ's board of directors are considered experienced (5.8 years average tenure).